Evidence map›Paper›PMID 9312184›Full record

ArticleThe Journal of clinical investigation1997

Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

L Rossetti, A E Stenbit, W Chen, M Hu, N Barzilai, E B Katz, M J Charron

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of clinical investigation, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

L RossettiDepartment of Medicine, Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA. rossetti@aecom.yu.edu
A E Stenbit
W Chen
M Hu
N Barzilai
E B Katz
M J Charron
Albert Einstein College of Medicine · USYeshiva University · US

Funding

REGULATION OF HEPATIC GLUCOSE FLUXESR01DK045024 · NIDDK · YESHIVA UNIVERSITY · PI GUTIERREZ-JUAREZ, ROGER · 1997 to 2010
$4.2M
BIOCHEMICAL MECHANISMS OF IN VIVO INSULIN RESISTANCER01DK048321 · NIDDK · YESHIVA UNIVERSITY · PI HAWKINS, MEREDITH A · 1994 to 2008
$3.1M
Regulation of Cardiac Glucose TransportersR01DK047425 · NIDDK · YESHIVA UNIVERSITY · PI CHARRON, MAUREEN J · 1995 to 2007
$2.3M
Biochemical Mechanisms of In Vivo Insulin ResistanceR37DK048321 · NIDDK · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ROSSETTI, LUCIANO · 2004 to 2005
$911k
INSULINOMINETIC PROBESR29DK045024 · NIDDK · YESHIVA UNIVERSITY · PI ROSSETTI, LUCIANO · 1991 to 1996
–
NIDDK NIH HHS DK-45024NIDDK NIH HHS DK-47425NIDDK NIH HHS DK-48321
6 · The paper itself

Abstract

Glucose transporter type 4 (GLUT4) is insulin responsive and is expressed in striated muscle and adipose tissue. To investigate the impact of a partial deficiency in the level of GLUT4 on in vivo insulin action, we examined glucose disposal and hepatic glucose production (HGP) during hyperinsulinemic clamp studies in 4-5-mo-old conscious mice with one disrupted GLUT4 allele [GLUT4 (+/-)], compared with wild-type control mice [WT (+/+)]. GLUT4 (+/-) mice were studied before the onset of hyperglycemia and had normal plasma glucose levels and a 50% increase in the fasting (6 h) plasma insulin concentrations. GLUT4 protein in muscle was approximately 45% less in GLUT4 (+/-) than in WT (+/+). Euglycemic hyperinsulinemic clamp studies were performed in combination with [3-3H]glucose to measure the rate of appearance of glucose and HGP, with [U-14C]-2-deoxyglucose to estimate muscle glucose transport in vivo, and with [U-14C]lactate to assess hepatic glucose fluxes. During the clamp studies, the rates of glucose infusion, glucose disappearance, glycolysis, glycogen synthesis, and muscle glucose uptake were approximately 55% decreased in GLUT4 (+/-), compared with WT (+/+) mice. The decreased rate of in vivo glycogen synthesis was due to decreased stimulation of glucose transport since insulin's activation of muscle glycogen synthase was similar in GLUT4 (+/-) and in WT (+/+) mice. By contrast, the ability of hyperinsulinemia to inhibit HGP was unaffected in GLUT4 (+/-). The normal regulation of hepatic glucose metabolism in GLUT4 (+/-) mice was further supported by the similar intrahepatic distribution of liver glucose fluxes through glucose cycling, gluconeogenesis, and glycogenolysis. We conclude that the disruption of one allele of the GLUT4 gene leads to severe peripheral but not hepatic insulin resistance. Thus, varying levels of GLUT4 protein in striated muscle and adipose tissue can markedly alter whole body glucose disposal. These differences most likely account for the interindividual variations in peripheral insulin action.

Indexed as

Muscle ProteinsAdipose TissueAllelesAnimalsBiological TransportBlood GlucoseGlucose Clamp TechniqueGlucose Transporter Type 4HyperinsulinismInsulinInsulin ResistanceLiverMaleMiceMice, Mutant StrainsMonosaccharide Transport ProteinsBlood GlucoseGlucose Transporter Type 4InsulinMonosaccharide Transport ProteinsMuscle ProteinsSlc2a4 protein, mouse

Identifiers

PMID9312184
PMCPMC508369
OpenAlexW2017958689

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.